SUBSCRIBE: Print / Digital / eNewsletter
A recent study found low levels of free testosterone in older men with prostate cancer could increase these men’s odds of facing erectile dysfunction after undergoing radical prostatectomy.
Urology Times interviewed four leading urologists who are experts in BPH to get their take on the most important BPH studies of 2018 and 2019.
A patient-reported outcomes survey that is widely used to determine whether men are experiencing erectile dysfunction (ED) fails to ask three critical questions that could uncover whether men truly have ED and the extent to which they face challenges, researchers say.
A study presented at the AUA annual meeting in Chicago shows higher rates of emergency department (ED) visits when ureteral access sheaths are used during ureteroscopy to remove kidney stones.
Forgotten stents are one of the most common challenges urologists and their patients face, and they can cause significant complications and increase costs of care. Now, a program that tracks stent insertion and removal in the electronic medical record shows strong potential to help eliminate retained stents.
High rates of residual fragments after ureteroscopy point to the need to both improve selection of patients for this procedure and find ways to boost stone-free rates, according to researchers at UT Southwestern Medical Center, Dallas.
As the number of patients who receive onabotulinumtoxinA (onabotA [Botox]) injections for overactive bladder increases, so does the age of this population and their associated comorbidities. This raises the question: Is the use of onabotA in patients who are taking anticoagulant or antiplatelet medication safe?
Three novel androgen receptor inhibitors provide an embarrassment of riches when it comes to treatment options for nmCRPC patients, but there are still questions to be answered—including the extent of these drugs’ clinical benefit.
A recent study shows older women with decreased levels of serum testosterone are more likely to experience incontinence, but this does not necessarily mean urologists should be giving testosterone to older women, a study author says.
Are dip tests needed for onabotulinumtoxinA (onabotA [Botox]) bladder procedures when no symptoms of urinary tract infection are present? A recent study presented at the AUA annual meeting in Chicago suggests the answer may be no.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.
